ENDRA Life Sciences Inc (NAS:NDRA)
$ 5.16 -0.305 (-5.58%) Market Cap: 2.77 Mil Enterprise Value: -1.57 Mil PE Ratio: 0 PB Ratio: 0.42 GF Score: 30/100

Q3 2020 ENDRA Life Sciences Inc Earnings Call Transcript

Nov 16, 2020 / 09:30PM GMT
Release Date Price: $28378.03 (-3.93%)
Operator

Good day, ladies and gentlemen, and welcome to the ENDRA Life Sciences third-quarter 2020 earnings conference call. All lines have been placed on a listen-only mode and the floor will be opened for your questions and comments following the presentation.

At this time, it is my pleasure to turn the floor over to your host for today, Ms. Kim Golodetz. Ma'am, the floor is yours.

Kim Golodetz
LHA Investor Relations - IR

Thank you, Jess. This is Kim Golodetz with LHA, ENDRA's recently engaged Investor Relations firm. Good afternoon, and welcome to ENDRA's third-quarter 2020 business update and financial results conference call. ENDRA issued a press release on this topic earlier this afternoon. For those of you who don't have a copy of the release, you can access it in the Investors section of ENDRA's website at www.endrainc.com.

Before we begin, please note that today's presentation includes forward-looking statements. All statements other than statements of historical facts,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot